101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen

Money Maze Podcast

Business, Investing, Management, News, Business News

4.8 • 216 Ratings

🗓️ 29 June 2023

⏱️ 40 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”.

If you want see how biotech can change the world of health, whilst potentially being capable of creating extraordinary value for investors, there are few better places to look than Amgen, one of the world’s leading independent biotech companies. With a market capitalisation of approximately $130bn, Amgen has been an extraordinary success story.

In this conversation Bob discusses the big areas of medical need, from cardiovascular problems which continue to make it the world’s greatest killer, through to genetics, obesity, osteoporosis, and cancers.

Bob discusses timelines and priorities, the use of AI in accelerating drug development, biologics, facing setbacks on the road to approvals, and the challenge of running a company which has a presence in over 100 countries.

Sign up to our newsletter for more in-depth insights | Follow us on LinkedIn

The Money Maze Podcast is kindly sponsored by Schroders, Bremont Watches, LiveTrade and Mintus.

Transcript

Click on a timestamp to play from that location

0:00.0	We need to recognize that we're in a hotly competitive field. And one of the things Amgen prizes
0:05.5	is competing intensely to win. That's not just about the effort. It's about making a difference for
0:09.8	patients. Welcome to the Money Maze podcast. I'm Simon Brewer and Will Campion and I have created
0:16.1	this show to explore and unravel some of the mysteries surrounding the investment business.
0:21.1	You can keep up to date by visiting Moneymayspodcast.com, and please sign up to our newsletter
0:26.1	to ensure you won't miss a release. If you enjoy this show, please subscribe, and we'd love you
0:31.3	to tell a friend or colleague about it. Thank you for listening.
0:35.2	The late, brilliant Steve Jobs said,
0:38.0	I think the biggest innovation of the 21st century
0:40.6	will be at the intersection of biology and technology.
0:44.2	A new era is beginning.
0:46.5	And if you want to see how biotech can change the world of health
0:49.8	and also create extraordinary value for investors,
0:52.6	you need to look no further than Amgen,
0:55.5	one of the world's leading independent biotech companies. Now, looking no further means me here
1:00.6	today in London and my guest in San Diego, but it's not every day we get to talk to the CEO of
1:06.0	one of the top 60 most valuable companies in the US, with a market cap of around $130 billion. So today I'm
1:14.0	thrilled to welcome Amgen CEO and chairman Bob Bradway. Bob, welcome to the Moneyways podcast.
1:19.9	Thank you, Simon. Great to be here with you. Well, we met at Morgan Stanley a long time ago.
1:26.2	You were there for, I think, nearly 20 years, and we actually
1:29.0	both left the same year. And you were known as the gentleman banker setting very high standards,
1:35.1	and you've had a very impressive second career. And we're going to talk about that in a minute.
	...

Transcript will be available on the free plan in -638 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Money Maze Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Money Maze Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.